0001209191-14-009833.txt : 20140212
0001209191-14-009833.hdr.sgml : 20140212
20140212180034
ACCESSION NUMBER: 0001209191-14-009833
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140212
FILED AS OF DATE: 20140212
DATE AS OF CHANGE: 20140212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Public Joint Stock Co Pharmstandard
CENTRAL INDEX KEY: 0001598754
STATE OF INCORPORATION: 1Z
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 14601837
BUSINESS ADDRESS:
STREET 1: LIKHACHEVSKY DRIVE
STREET 2: 5 "B"
CITY: DOLGOPRUDNY
STATE: 1Z
ZIP: 141701
BUSINESS PHONE: 7 495 970 0032
MAIL ADDRESS:
STREET 1: LIKHACHEVSKY DRIVE
STREET 2: 5 "B"
CITY: DOLGOPRUDNY
STATE: 1Z
ZIP: 141701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pharmstandard International S.A.
CENTRAL INDEX KEY: 0001598762
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 14601838
BUSINESS ADDRESS:
STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-1528
BUSINESS PHONE: 352 26449 557
MAIL ADDRESS:
STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE
CITY: LUXEMBOURG
STATE: N4
ZIP: L-1528
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-02-12
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001598762
Pharmstandard International S.A.
65, BOULEVARD GRANDE DUCHESSE CHARLOTTE
LUXEMBOURG
N4
L-1331
LUXEMBOURG
0
0
1
0
0001598754
Public Joint Stock Co Pharmstandard
LIKHACHEVSKY DRIVE 5 "B"
DOLGOPRUDNY
1Z
1417000
RUSSIAN FEDERATION
0
0
1
0
Common Stock
2014-02-12
4
C
0
4708549
A
4708549
I
See footnote
Common Stock
2014-02-12
4
P
0
1275000
8.00
A
5983549
I
See footnote
Series E Preferred Stock
2014-02-12
4
C
0
4708549
0.00
D
Common Stock
4708549
0
I
See footnote
Each share of Series E Preferred Stock converted into 0.1667 shares of common stock upon the closing of the Issuer's initial public offering of common stock for no additional consideration. The Series E Preferred Stock has no expiration date.
Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company "Pharmsandard". As the parent entity, Public Joint Stock Company "Pharmstandard" has voting and investment power over the shares of the Issuer held by Pharmstandard International S.A.
/s/ Gerard Birchen
2014-02-12
/s/ Eriks Martinovskis
2014-02-12